Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jerome Lorenzini has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Camille Mimoun

    Service de gynécologie obstétrique, hôpital Lariboisière, Paris-Cité université, AP-HP, Paris, France

    2 shared publications
  • Cyril Touboul

    Department of Gynecology-Obstetrics, Expert center in Gynecology-Oncology, Tenon Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Sorbonne University, Paris, France

    2 shared publications
  • Cyrille Huchon

    APHP. Service de gynécologie & obstétrique, GH Saint-Louis Lariboisière-Fernand Widal, Hôpital Lariboisière, Université de Paris, 2, rue Ambroise Paré, 75010 Paris, France

    2 shared publications
  • Lobna Ouldamer

    Department of Gynaecology, Centre Hospitalier Universitaire de Tours, Tours, France; INSERM U1069 Université François-Rabelais, Tours, France

    2 shared publications
  • Vincent Lavoué

    Department of Gynaecology, CHU de Rennes, France; INSERM, 1242, COSS, Rennes, Université de Rennes 1, France

    2 shared publications
  • Yohann Dabi

    Department of Gynaecology and Obstetrics, Tenon University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Faculté de Médecine Sorbonne Université, Institut Universitaire de Cancérologie (IUC), France

    2 shared publications

Latest Publications

  • Open Access

    Impact of lymph node staging on survival in presumed early-stage ovarian cancer: a multicentric retrospective study

    by Samia Ouasti, Julie Alline, Yohan Kerbage, Elie Zerbib, Lobna Ouldamer, Sofiane Bendifallah, Cyrille Huchon, Jerome Lorenzini, Vincent Lavoué, Emilie Raimond, et al.

    Ouasti S, et al. J Gynecol Oncol. 2025 Nov;37:e31. https://doi.org/10.3802/jgo.2026.37.e31

  • Open Access

    Presentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary

    by Marine Huin, Jerome Lorenzini, Flavie Arbion, Xavier Carcopino, Cyril Touboul, Yohann Dabi, Yohan Kerbage, Hélène Costaz, Lise Lecointre, Vincent Lavoué, et al.

    Objective: The aim of the present study was to evaluate evolution and prognosis of mucinous ovarian carcinomas (mOC), with respect to the two invasive patterns: expansile and infiltrative invasion. Methods: This was a descriptive, retrospective, multicenter study conducted in 13 French centres from 1 January 2001 to 31 December 2019. All patients operated on for epithelial ovarian neoplasia of the mucinous type (infiltrative/expansile) were included, whether the surgery was performed immediately or after neoadjuvant chemotherapy. Results: A total of 94 women with mucinous carcinomas were included in the present study. Mucinous tumours were divided into 35 expansile (37%) and 59 infiltrative (63%) mOC. There was a statistically significant difference in early and late stages at initial diagnosis between expansile and infiltrative mOC. None of the expansile mOC showed metastatic lymph nodes, whereas almost a quarter of the infiltrative mOC were metastatic to the pelvic/para-aortic region. There was a clear difference in RFS, in favour of expansile mOC, with 90% survival at 5 years, compared with 60% for infiltrative mOC. Conclusions: Although infiltrative and expansile mOC belong to the same histological family, they present many distinctions in clinical presentation, histological invasion, and disease course.